Ken Research - Vietnam Pharmaceutical Import And Export

Vietnam Pharmaceutical Market is Expected to Reach around USD 10.1 Billion in
2022: Ken Research
Vietnam Pharmaceutical market by Generic and Patented drugs, by Prescribed Drugs and
OTC Drugs and Therapeutic Drugs (Metabolism and Nutritional Medicine, Cardiovascular,
Central Nervous System, System Infection, Oncology, Musculoskeletal, Respiratory and
Others) along with company profiles of DHG Pharma, Traphaco, Pymepharco, Ha Tey
Pharmaceutical, Mekophar, Domesco, Imexpharma, OPC, Sanofi, GSK, AstraZeneca,
Novartis, Roche, Pfizer, MSD and Bayer


Rise in generic drug usage and growth in self-medication in Vietnam will
foster the growth of Pharmaceutical industry in Vietnam.
Government initiative to produce higher quality pharmaceuticals in Vietnam
will impact the market positively.
Government has focused on developing research facilities and training of local
talent. Under the biotechnology drive target by 2020, government is helping
pharmaceutical producers to develop expertise through foreign assistance.
Government’s push for production and utilization of locally produced generic drugs
will boost usage of generic drugs. Therapeutic segments such as oncology and
diabetes management will continue to witness high demand for patented drugs. Rise
in number of drug manufacturers will also aid in rise of generic drug usage. Trend in